Insider filings made public on Tuesday reveal a cluster of significant equity transactions across a range of sectors, from consumer packaged goods and produce distribution to technology and energy. The activity includes both affirming purchases by corporate insiders and major shareholders, and large monetizations by funds and directors. The details below reflect filings with the Securities and Exchange Commission and company disclosures.
Top insider buys
Energizer Holdings, Inc. (ENR) reported a material purchase by a 10% owner. Aqua Capital, Ltd. acquired 40,000 shares of common stock on June 22, 2026, for a total of $843,832. The trades were executed at weighted average prices ranging from $21.0906 to $21.101 per share. Energizer shares are quoted at $21.59 and have appreciated nearly 6% over the past week. The stock is trading at a price-to-earnings ratio of 7.77 and carries a dividend yield of 5.56%. Aqua Capital directly owns the shares and operates as a wholly owned subsidiary of Durango Capital, Ltd., which in turn is owned 50% by The Apollo Trust and 50% by The Minerva Trust. Fundacion Omerinta is named as the Protector of both trusts, with authority over trustee appointments. Brinza International Corp. is the founder and sole member of Fundacion Omerinta's Foundation Council. Alfredo Jose Diez Ramirez is identified as the Founder and Protector of Fundacion Barniz and as the sole director and president of Durango Capital, Ltd.
Mission Produce, Inc. (AVO) saw a director increase his stake through open-market purchases. Bruce C. Taylor bought a total of 100,000 shares of common stock across two days, spending roughly $1,128,268. According to a Form 4 filed with the SEC, Mr. Taylor purchased 29,717 shares on June 22, 2026, at $11.36 per share and added 70,283 shares on June 23, 2026, at $11.25 per share. Mission Produce is trading at $11.71 and carries a market capitalization of $1.03 billion. The company is profitable over the last twelve months and, at current market prices, is characterized in the filing as appearing undervalued per InvestingPro analysis.
Autodesk, Inc. (ADSK) recorded a purchase by director John T. Cahill. On June 23, 2026, Mr. Cahill acquired 2,000 shares of common stock for a total reported value of $378,400. The shares were bought at an average weighted price of $189.20 each, with individual transaction prices ranging from $188.94 to $189.39. Autodesk shares are trading at $188.75, approximately 2% above their 52-week low of $185.50. The filing indicates the purchase was executed indirectly through a revocable trust. Following the transaction, indirect holdings attributed to the John Tobin Cahill Revocable Trust UA April 24, 2003 increased to 4,000 shares. Separately, Mr. Cahill holds 3,917 shares directly, which includes 2,174 unvested Restricted Stock Units, and an additional 60 shares are held indirectly through the John T. Cahill Gift Trust.
Tempest Therapeutics, Inc. (TPST) registered a sizable indirect acquisition by its CEO and President. Matthew Angel, who is also a director and a 10% owner of Tempest Therapeutics, is reported to have indirectly acquired 231,482 shares of common stock at $2.16 per share on March 24, 2026, according to a Form 4 filed June 23, 2026. The transaction amounts to approximately $500,001. The filing states the acquisition was made by Factor Bioscience Inc., where Mr. Angel is the majority stockholder and serves as Chairman of the Board, and that he exercises voting and investment power over the shares held by Factor. Tempest shares have since fallen substantially and trade at $1.25, near the 52-week low of $1.22. Over the last year the stock has declined more than 80% and the company maintains a market capitalization of $18.66 million. The filing notes that InvestingPro analysis indicates the stock appears undervalued and references additional ProTips available to subscribers.
Amplify Energy Corp. (AMPY) showed insider buying from the company’s President and Chief Financial Officer. James Frew purchased 25,000 shares of common stock on June 23, 2026, at $3.95 per share, for a total outlay of $98,750. Following that purchase, the filing reports Mr. Frew directly holds 216,859 shares of Amplify Energy common stock.
Top insider sells
Spyre Therapeutics, Inc. (SYRE) experienced a substantial disposition tied to an affiliated investment fund. Fairmount Healthcare Fund II L.P., an investment vehicle affiliated with a director, sold 4,684,781 shares of common stock for proceeds of $399,658,667 on June 23, 2026. The shares were sold at $85.31 per share. The filing notes that the sale followed the conversion of Series B Preferred Stock into common shares by Fairmount Healthcare Fund II L.P.; on the same day the fund converted 16,667 shares of Series B Preferred Stock into 666,680 shares of common stock on a conversion ratio of 1 share of Series B Preferred into 40 shares of common stock, subject to beneficial ownership limitations. The conversion occurred for no cash consideration. Since the sale, Spyre’s stock has traded up to $97.05, which is 13.8% above the $85.31 sale price. The shares are trading near a 52-week high of $102.06 and are described in the filing as appearing overvalued on a Fair Value basis.
Hyatt Hotels Corp. (H) reported multiple executive sales totaling tens of millions of dollars. Chairman, President and Chief Executive Officer Mark Samuel Hoplamazian sold company stock amounting to roughly $23.8 million across several transactions executed between June 18 and June 22, 2026. Sale prices ranged from $195.96 to $205.23 per share. The filing highlights that these sales took place while Hyatt shares were trading near a 52-week high of $206.86 following a strong 50% gain over the past year. On June 18 specifically, Mr. Hoplamazian sold 35,209 shares of Class A common stock at prices between $202.00 and $205.47 per share.
ARGAN INC (AGX) disclosed a two-date sale by its Non-Executive Chairman and Director. William F Jr Griffin sold a combined 50,000 shares in June, resulting in proceeds of approximately $36.9 million. A Form 4 shows 30,000 shares were sold on June 18, 2026, on the open market at an average price of $725.85 per share, and an additional 20,000 shares were sold on June 22, 2026, at an average price of $760.43 per share.
ST JOE Co (JOE) recorded a sale by 10% owners. Fairholme Funds Inc. and Bruce R. Berkowitz reported the sale of 140,400 shares of common stock on June 18, 2026, at $65.71 per share, for total proceeds of approximately $9.23 million. The filing was submitted on June 23, 2026. ST JOE shares trade at $66.31 and have gained 39% over the past year. The filing characterizes the shares as overvalued relative to a Fair Value estimate.
NVIDIA Corp. (NVDA) saw a substantial block sale by trusts linked to a director. Director Mark A. Stevens reported that trusts associated with him sold a total of 885,000 shares of common stock on June 18, 2026, in transactions totaling roughly $186 million. The company’s shares are trading at $200 and the filing lists the company's market capitalization at $4.87 trillion. The disclosure states the sales were completed in two separate transactions. The first involved 319,385 shares sold at a weighted average price of $209.6952 per share, with prices ranging from $209.0600 to $210.0594. The second transaction comprised 565,615 shares sold at a weighted average price of $210.4372 per share, with prices ranging from $210.0598 to $211.0100. Both sets of shares were held indirectly by the Third Millennium Trust, for which Mr. Stevens and his wife serve as co-trustees. The filing also notes that InvestingPro analysis currently indicates the stock appears undervalued and that shares have returned 45% over the past year.
Context and takeaways
The recent filings illustrate the range of motivations and structures behind insider transactions. The purchases at Energizer and Mission Produce were executed by long-standing owners or directors and are reported as direct or indirect acquisitions, in some cases through trusts or affiliated entities. Similarly, the Autodesk and Amplify purchases were executed by directors or executive officers through trusts or direct buys, increasing disclosed holdings.
On the sell side, several large dispositions were routed through investment funds, trusts or direct open-market executions. The very large sale by Fairmount Healthcare Fund II L.P. in Spyre followed a conversion of preferred shares into common stock, a transaction that produced a large block of common shares available for sale. Other sales by senior executives and directors at Hyatt, ARGAN and NVIDIA generated tens to hundreds of millions of dollars in proceeds and were carried out while those stocks traded near multi-month highs for some names.
What these filings do not reveal
- Individual filings do not fully disclose the motivations behind each transaction beyond the mechanics and ownership structures detailed on Form 4s. Executives and major shareholders may sell for tax planning, diversification, estate planning or other personal reasons that are not specified in the filings.
- The filings show ownership and transaction mechanics, including the role of trusts, subsidiaries and affiliated funds, but they do not quantify how these moves will affect company operations or near-term strategy.
- Market reaction subsequent to a sale or purchase can move stock prices independently of the filing details; for example, Spyre’s shares traded higher after the Fund II sale, and multiple names are described as trading near 52-week highs or lows in the disclosure.
How investors may use this information
Insider activity can serve as one input among many for investment decisions. Purchases by insiders may be interpreted as a sign of confidence in a company’s prospects, while sales may reflect personal financial planning or other non-fundamental reasons. Each reported transaction here includes specifics on price, timing and ownership chains that can be combined with fundamental and technical analysis to build a fuller picture. The filings also highlight the prevalence of trust and fund structures as intermediaries for insider activity, underscoring the importance of understanding who ultimately exercises voting and investment power over shares.
For market participants focusing on materials, mining and related supply chains, the transactions in this set are more relevant from a market-structure and capital-allocation perspective than as indicators of commodity demand: the purchases and sales involve consumer, software, biotech and energy companies where insider moves reflect company-specific capital management rather than sector-wide commodity signals.
Final note
These disclosures provide transparent snapshots of how company insiders and affiliated funds are allocating capital in public equities. While the mechanical details are explicit in filings - number of shares, prices, dates and ownership vehicles - the economic or strategic rationale behind individual trades is not. Monitoring future filings and combining this data with broader fundamental analysis can help investors contextualize the significance of insider buys and sells.